Clinical Trials in New York

Showing 10181-10200 of 22,668 trials

Demonstration of a Digital Care Program for Methamphetamine Use Disorder

NCT05206175

This Phase I Small Business Innovation Research (SBIR) project will examine the technical merit and real-world feasibility of the Affect smartphone application ("app") as the core component of the Affect digital care program for treatment of methamphetamine use disorder (MUD).

Methamphetamine Abuse

Affect Therapeutics, Inc.100 participantsStarted Feb 2022

New York, New York, United States

COMPLETEDPhase 3< 1 mile

Study of Etanercept Monotherapy vs Methotrexate Monotherapy for Maintenance of Rheumatoid Arthritis Remission

NCT02373813

The purpose of this study is to evaluate the efficacy of etanercept monotherapy compared to methotrexate monotherapy on maintenance of remission in participants with rheumatoid arthritis (RA) who were on etanercept plus methotrexate therapy. This is a multicenter, randomized withdrawal, double-blind controlled study in participants with rheumatoid arthritis on etanercept plus methotrexate therapy who are in very good disease control for 6 months prior to study entry. The study will consist of a 30-day screening period, a 24-week open label run-in period, a 48-week double-blind treatment period and a 30-day safety follow-up period.

Rheumatoid Arthritis

Amgen371 participantsStarted Feb 2015

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Huntsville, Alabama, United States +133 more locations

Demonstration of a Digital Care Program for Methamphetamine Use Disorder

Study of Etanercept Monotherapy vs Methotrexate Monotherapy for Maintenance of Rheumatoid Arthritis Remission

Find Trials by Condition in New York

Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma

BREATHE: An Efficacy-implementation With Listening Sessions

S0521, Combination Chemotherapy With or Without Gemtuzumab Followed By Tretinoin, Mercaptopurine, and Methotrexate or Observation in Treating Patients With Acute Promyelocytic Leukemia

Comparison of a Daily Disposable Multifocal Contact Lens to a Marketed Product

Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed, Non-metastatic Desmoplastic Medulloblastoma

Ribavirin for Patients With Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies

Electroretinogram: a New Human Biomarker for Smoking Cessation Treatment

Efficacy, Tolerability, and Safety of DFN-15

Trial of Ultrasound Guidance for Reduction of Pediatric Forearm Fractures

Trial of Inhaled Molgramostim in Cystic Fibrosis Subjects With Nontuberculous Mycobacterial Infection

Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis

A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat

Safety of RIV4 Versus IIV4 in Pregnant Women

A Study of Combination Nivolumab and Ipilimumab Retreatment in Patients With Advanced Renal Cell Carcinoma

A Study of Long-Term Responders on Olaparib

A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Emicizumab Given Every 4 Weeks in Participants With Hemophilia A

A Study of Respiratory Muscle Strength in Patients With Late-onset Pompe Disease (LOPD)

BEMPEG With Pembrolizumab vs Pembrolizumab Alone in Patients With Metastatic or Recurrent HNSCC (PROPEL-36)